Wells Fargo & Company Myriad Genetics Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Myriad Genetics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 126,468 shares of MYGN stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,468

Previous 131,493 3.82%

Holding current value

$1.57 Million

Previous $3.22 Million 7.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.97 - $28.6 $120,449 - $143,715	-5,025 Reduced 3.82%	126,468 $3.46 Million
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $67,748 - $95,970	-3,768 Reduced 2.79%	131,493 $3.22 Million
Q1 2024 May 10, 2024	SELL	$17.59 - $23.59 $719,202 - $964,524	-40,887 Reduced 23.21%	135,261 $2.88 Million
Q4 2023 Feb 09, 2024	SELL	$13.91 - $21.32 $1.61 Million - $2.46 Million	-115,511 Reduced 39.6%	176,148 $3.37 Million
Q3 2023 Nov 13, 2023	SELL	$15.99 - $23.22 $187,802 - $272,718	-11,745 Reduced 3.87%	291,659 $4.68 Million
Q2 2023 Aug 15, 2023	SELL	$17.56 - $23.76 $51,696 - $69,949	-2,944 Reduced 0.96%	303,404 $7.03 Million
Q1 2023 May 12, 2023	BUY	$15.26 - $23.75 $970,047 - $1.51 Million	63,568 Added 26.18%	306,348 $7.12 Million
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $1.63 Million - $2.35 Million	-112,175 Reduced 31.6%	242,780 $3.52 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $54,375 - $83,249	-2,986 Reduced 0.83%	354,955 $6.77 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $716,413 - $1.13 Million	-43,551 Reduced 10.85%	357,941 $6.5 Million
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $1.25 Million - $1.55 Million	55,260 Added 15.96%	401,492 $10.1 Million
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $1.95 Million - $2.64 Million	-80,860 Reduced 18.93%	346,232 $9.56 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $139,360 - $170,468	-4,650 Reduced 1.08%	427,092 $13.8 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $2.12 Million - $2.73 Million	-83,653 Reduced 16.23%	431,742 $13.2 Million
Q1 2021 May 13, 2021	SELL	$19.92 - $31.6 $584,432 - $927,112	-29,339 Reduced 5.39%	515,395 $15.7 Million
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $213,420 - $346,983	-17,551 Reduced 3.12%	544,734 $10.8 Million
Q3 2020 Nov 05, 2020	BUY	$11.25 - $14.75 $139,770 - $183,254	12,424 Added 2.26%	562,285 $7.33 Million
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $1.7 Million - $2.62 Million	158,720 Added 40.58%	549,861 $6.24 Million
Q1 2020 May 14, 2020	BUY	$9.78 - $29.53 $3.83 Million - $11.6 Million	391,141 New	391,141 $5.6 Million

Others Institutions Holding MYGN

# of Institutions

246

Shares Held

91.6M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Myriad Genetics Inc Transaction History